RBS out : Profitibily for the 1st 6 months . Net asset value is nearly 22 million which suggests around 3.9 p per share which is well well over existing price. Should get a proper re rating over 3 p soon
RE: UK Gov planning for Digital immunity passport13 Sep 2020 12:34
Whether CTEA has any part of it - I don’t know - the main point is - CTEA already COVID- passport ready & their marketing then now looking to get the commercial deals . If this UK gov has any part of CTEA covid passport - it will be a huge thing. With a commercial deal we can the share price at least 10p-12p Also buying around 2.5 million share suggests confidence investors has on CTEA. Most important part is —CTEA needs to get one deal done - then we can expect further commercial contracts. With the rising covid cases - COVID passport is a much needed thing.
UK Gov planning for Digital immunity passport13 Sep 2020 06:44
The UK government has drawn up plans to carry out up to 10 million covid-19 tests a day by early next year as part of a huge £100bn (€110bn; $130bn) expansion of its national testing programme, documents seen by The BMJ show.
Under the plan the government will roll out testing in workplaces, entertainment venues, and football stadiums and at GP surgeries, pharmacies, schools, and other local sites to improve access. It will also roll out digital immunity passports to allow people who test negative to return to workplaces, travel, and participate in other activities. https://www.bmj.com/content/370/bmj.m3520
Still existing valuation is too low10 Sep 2020 15:36
Discounted cash flows are summed over a prospective 10-years to which a terminal growth/contraction value is then added along with net cash, after offsetting anticipated administrative and continuing R&D costs for the period. This results in a £65.7m current valuation for Midatech, presently equivalent to 104.2p/share.
Good progress with the enhanced COVID-ID . As the world business is opening , premier league football, cricket & all - so an effective COVID-ID is must needed. One successful commercial deal will lead this company for further deals . Expecting a good rise on the SP - at least moving towards 8p
The important part of the RNS is getting worldwide excess : The new partner will use 7digital's platform to access a world-wide music catalogue from rights-secured labels, and the new deal also includes tracking and reporting services. Also more than 1 year contract.
We can not expect news all the time- news will come all in a sudden. Initially I also though tests on Botswana was a not that attractive. But later on when I read about the news - How Botswana is taking steps to tackle COVID, my confident going up - that something gonna happen. We have to be patient and see - we have seen this stock jumped from 3.5P to high over 9p. One the the patient is required.
Massive re-rating coming. According to their 20th July RNS They issued around 16M option share at over 3.5p with Vesting price starting from 10P up to 50P- which is a kind of indication with commercial news how far this company's share price can go. At this price - it is a excellent entry point.
only 60M share in issue, Over £16 million quick asset - where over £10m Working capital. Net asset value is over £32m , where market cap is only over £26M. Lombard Oider recently got over 9% recently - so big re-raring is coming. According to their recent RNS- with Collaboration extension with Q-Sphera-